European Perspectives


CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

Matteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano‐Trojaola, Santiago Barrio, Umair Munawar, Susanne Strifler, Larissa Haertle, Nadine Rhodes, Eva Teufel, Cornelia Vogt, Constantin Lapa, Andreas Beilhack, Leo Rasche, Hermann Einsele, K. Martin Kortüm

The Oncologist first published on October 18, 2019; doi: 10.1634/theoncologist.2019-0356


The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma

Sahra Ali, Rune Kjeken, Christiane Niederlaender, Greg Markey, Therese S. Saunders, Mona Opsata, Kristine Moltu, Bjørn Bremnes, Eirik Grønevik, Martine Muusse, Gro D. Håkonsen, Venke Skibeli, Maria Elisabeth Kalland, Ingrid Wang, Ingebjørg Buajordet, Ania Urbaniak, John Johnston, Khadija Rantell, Essam Kerwash, Martina Schuessler‐Lenz, Tomas Salmonson, Jonas Bergh, Christian Gisselbrecht, Kyriaki Tzogani, Irene Papadouli, Francesco Pignatti

The Oncologist first published on October 16, 2019; doi: 10.1634/theoncologist.2019-0233


Guillain‐Barré Syndrome During Platinum‐Based Chemotherapy: A Case Series and Review of the Literature

Evangelia Pappa, Giulia Berzero, Bastien Herlin, Damien Ricard, Camille Tafani, Perrine Devic, Denis Maillet, Alaina Borden, Karine Viala, Thierry Maisonobe, Timothée Lenglet, Nicolas Weiss, Dimitri Psimaras

The Oncologist first published on October 15, 2019; doi: 10.1634/theoncologist.2019-0255


A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Gabriella Macchia, Roberta Lazzari, Nicoletta Colombo, Concetta Laliscia, Giovanni Capelli, Giuseppe Roberto D'Agostino, Francesco Deodato, Ernesto Maranzano, Edy Ippolito, Sara Ronchi, Fabiola Paiar, Marta Scorsetti, Savino Cilla, Rossana Ingargiola, Alessandra Huscher, Anna Maria Cerrotta, Andrei Fodor, Lisa Vicenzi, Donatella Russo, Simona Borghesi, Elisabetta Perrucci, Sandro Pignata, Cynthia Aristei, Alessio Giuseppe Morganti, Giovanni Scambia, Vincenzo Valentini, Barbara Alicja Jereczek‐Fossa, Gabriella Ferrandina

The Oncologist first published on October 2, 2019; doi: 10.1634/theoncologist.2019-0328


Real‐World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10

Yvette Drew, Rebecca S. Kristeleit, Ana Oaknin, Isabelle Ray‐Coquard, Noor Md. Haris, Elizabeth M. Swisher

The Oncologist first published on October 1, 2019; doi: 10.1634/theoncologist.2019-0229


Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population‐Based Study

Anna Z. de Boer, Heleen C. van der Hulst, Nienke A. de Glas, Perla J. Marang‐van de Mheen, Sabine Siesling, Linda de Munck, Kelly M. de Ligt, Johanneke E. A. Portielje, Esther Bastiaannet, Gerrit Jan Liefers

The Oncologist first published on September 12, 2019; doi: 10.1634/theoncologist.2019-0412


Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers

Susanne Gahr, Sarah Lödel, Julia Berendt, Michael Thomas, Christoph Ostgathe

The Oncologist first published on September 10, 2019; doi: 10.1634/theoncologist.2019-0126


The Oncology Data Network (ODN): A Collaborative European Data‐Sharing Platform to Inform Cancer Care

David Kerr, Dirk Arnold, Jean‐Yves Blay, Christian Buske, Alfredo Carrato, Winald Gerritsen, Marc Peters

The Oncologist first published on September 5, 2019; doi: 10.1634/theoncologist.2019-0337


Lifetime Transfusion Burden and Transfusion‐Related Iron Overload in Adult Survivors of Solid Malignancies

F.J. Sherida H. Woei‐A‐Jin, Shu Zhen Zheng, Inci Kiliçsoy, Francisca Hudig, Saskia A.C. Luelmo, Judith R. Kroep, Hildo J. Lamb, Susanne Osanto

The Oncologist first published on August 27, 2019; doi: 10.1634/theoncologist.2019-0222


Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value

Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Maria Vittoria Dieci

The Oncologist first published on August 23, 2019; doi:10.1634/theoncologist.2019-0197


Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial

Sara Mijwel, Kate A. Bolam, Jacob Gerrevall, Theodoros Foukakis, Yvonne Wengström, Helene Rundqvist

The Oncologist first published on August 7, 2019; doi: 10.1634/theoncologist.2019-0262


Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study

Frédérique Retornaz, Olivier Guillem, Frédérique Rousseau, Francois Morvan, Yves Rinaldi, Sophie Nahon, Chantal Castagna, Rabia Boulahssass, Michel Grino, Dany Gholam

The Oncologist first published on August 6, 2019; doi: 10.1634/theoncologist.2019-0241


Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis

Casper Reijnen, Joanna IntHout, Leon F.A.G. Massuger, Fleur Strobbe, Heidi V.N. Küsters‐Vandevelde, Ingfrid S. Haldorsen, Marc P.L.M. Snijders, Johanna M.A. Pijnenborg

The Oncologist first published on July 19, 2019; doi:10.1634/theoncologist.2019-0166


Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen‐Activated Protein Kinase Pathway Alterations

William Boisseau, Philipp Euskirchen, Karima Mokhtari, Caroline Dehais, Mehdi Touat, Khê Hoang‐Xuan, Marc Sanson, Laurent Capelle, Aurélien Nouet, Carine Karachi, Franck Bielle, Justine Guégan, Yannick Marie, Nadine Martin‐Duverneuil, Luc Taillandier, Audrey Rousseau, Jean‐Yves Delattre, Ahmed Idbaih

The Oncologist first published published on July 25, 2019; doi:10.1634/theoncologist.2019-0223


Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors

Jaume Capdevila, Jorge Hernando, Santiago Perez‐Hoyos, Alejandro Roman‐Gonzalez, Enrique Grande

The Oncologist first published on on July 22, 2019; doi:10.1634/theoncologist.2018-0675


Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey

Florence Canouï‐Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez‐Trabada‐Ataz, Isabelle Baumgaertner, Olivier Dubreuil, Francesco Brunetti, Romain Coriat, Karin Maley, Simon Pernot, Christophe Tournigand, Meoin Hagege, Thomas Aparicio, Elena Paillaud, Sylvie Bastuji‐Garin

The Oncologist first published on July 19, 2019; doi:10.1634/theoncologist.2019-0166


Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer

Nadina Tinsley, Cong Zhou, Grace Tan, Samuel Rack, Paul Lorigan, Fiona Blackhall, Matthew Krebs, Louise Carter, Fiona Thistlethwaite, Donna Graham, Natalie Cook

The Oncologist first published on July 10, 2019; doi: 10.1634/theoncologist.2019-0160


Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2)

Ricarda Merten, Oliver Ott, Marlen Haderlein, Simone Bertz, Arndt Hartmann, Bernd Wullich, Bastian Keck, Reinhard Kühn, Claus Michael Rödel, Christian Weiss, Christine Gall, Wolfgang Uter, Rainer Fietkau

The Oncologist first published on July 10, 2019; doi:10.1634/theoncologist.2018-0280


Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)

Xabier García-Albéniz, Vicente Alonso, Pilar Escudero, Miguel Méndez, Javier Gallego, Jose Ramon Rodríguez, Antonia Salud, Julen Fernández-Plana, Hermini Manzano, Montserrat Zanui, Ester Falcó, Jaime Feliu, Mireia Gil, Carlos Fernández-Martos, Uriel Bohn, Carmen Alonso, Veró nica Calderero, Federico Rojo, Miriam Cuatrecasas, Joan Maurel

The Oncologist first published on June 24, 2019; doi:10.1634/theoncologist.2018-0728


Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

Véronique Diéras, Nadia Harbeck, Anil Abraham Joy, Karen Gelmon, Johannes Ettl, Sunil Verma, Dongrui R. Lu, Eric Gauthier, Patrick Schnell, Ave Mori, Hope S. Rugo, Richard S. Finn

The Oncologist first published on June 19, 2019; doi:10.1634/theoncologist.2019-0019


Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update

Francesco Izzo, Vincenza Granata, Roberto Grassi, Roberta Fusco, Raffaele Palaia, Paolo Delrio, Gianpaolo Carrafiello, Daniel Azoulay, Antonella Petrillo, Steven A Curley

The Oncologist first published on June 19, 2019; doi:10.1634/theoncologist.2018-0337


Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey

Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, Olivier Dubreuil, Francesco Brunetti, Romain Coriat, Karin Maley, Simon Pernot, Christophe Tournigand, Meoin Hagege, Thomas Aparicio, Elena Paillaud, Sylvie Bastuji-Garin

The Oncologist first published on June 11, 2019; doi:10.1634/theoncologist.2019-0117


Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis

Pauline Rochefort, Audrey Lardy-Cleaud, Matthieu Sarabi, Françoise Desseigne, Anne Cattey-Javouhey, Christelle de la Fouchardière

The Oncologist first published on June 4, 2019; doi:10.1634/theoncologist.2018-0786


Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

Maria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, Marta Mion, Paolo Morandi, Emilio Bria, Laura Merlini, Pierluigi Bullian, Cristina Oliani, Stefania Gori, Tommaso Giarratano, Enrico Orvieto, Gaia Griguolo, Silvia Michieletto, Tania Saibene, Paola Del Bianco, Gian Luca De Salvo, PierFranco Conte, on behalf of the Veneto Oncology Network

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2019-0103


Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

Christelle de la Fouchardiére, Romain Cohen, David Malka, Rosine Guimbaud, Héloïse Bourien, Astrid Lièvre, Wulfran Cacheux, Pascal Artru, Eric François, Marine Gilabert, Emmanuelle Samalin-Scalzi, Aziz Zaanan, Vincent Hautefeuille, Benoit Rousseau, Hélène Senellart, Romain Coriat, Ronan Flippot, Françoise Desseigne, Audrey Lardy-Cleaud, David Tougeron

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2018-0914


Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis

Ana Fernández Montes, Carlos López López, Guillem Argilés Martínez, David Páez López, Ana María López Muñoz, Beatriz García Paredes, David Gutiérrez Abad, Carmen Castañón López, Paula Jiménez Fonseca, Javier Gallego Plazas, María Carmen López Doldán, Eva Martínez de Castro, Manuel Sánchez Cánovas, María Tobeña Puyal, Beatriz Llorente Ayala, Ignacio Juez Martel, Mariana López Flores, Alberto Carmona-Bayonas

The Oncologist first published on May 30, 2019; doi:10.1634/theoncologist.2018-0824


Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France

Justine Gantzer, Antonio Di Marco, Thibaut Fabacher, Noelle Weingertner, Jean-Baptiste Delhorme, David Brinkert, Guillaume Bierry, Jean-Pierre Ghnassia, Jérémie Jégu, Jean-Emmanuel Kurtz

The Oncologist first published on May 9, 2019; doi:10.1634/theoncologist.2018-0751


Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer

Giuseppe Curigliano, Evandro de Azambuja, Daniel Lenihan, Maria Grazia Calabrò, Daniela Cardinale, Carlo Maria Cipolla

The Oncologist first published on May 7, 2019; doi:10.1634/theoncologist.2018-0773


Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

Astrid Lipplaa, Judith R. Kroep, Lizz van der Heijden, Paul C. Jutte, Pancras C.W. Hogendoorn, Sander Dijkstra, Hans Gelderblom

The Oncologist first published on April 30, 2019; doi:10.1634/theoncologist.2019-0280


A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer

Eva Ciruelos, María Apellániz-Ruiz, Blanca Cantos, Noelia Martinez-Jáñez, Coralia Bueno-Muiño, Maria-Jose Echarri, Santos Enrech, Juan-Antonio Guerra, Luis Manso, Tomas Pascual, Cristina Dominguez, Juan-Francisco Gonzalo, Juan-Luis Sanz, Cristina Rodriguez-Antona, Juan-Manuel Sepúlveda

The Oncologist first published on April 25, 2019; doi:10.1634/theoncologist.2017-0664


Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis

Kevin Bourcier, Derek Dinart, Axel Le Cesne, Charles Honoré, Pierre Meeus, Jean-Yves Blay, Audrey Michot, François Le Loarer, Antoine Italiano

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0641


Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, Ilaria Attili, Paola Del Bianco, Giulia Pasello, Valentina Guarneri, Giuseppe Aprile, PierFranco Conte, Laura Bonanno

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0563


Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo De Marinis, Andrea Ardizzoni, Fabiana Vitiello, Giuseppe Lo Russo, Hector Soto Parra, Enrico Cortesi, Federico Cappuzzo, Luana Calabrò, Marcello Tiseo, Daniele Turci, Teresa Gamucci, Paola Antonelli, Alessandro Morabito, Antonio Chella, Diana Giannarelli, Domenico Galetta

The Oncologist first published on April 17, 2019; doi:10.1634/theoncologist.2018-0737


"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer

Claribel Simmons, Donald C. McMillan, Sharon Tuck, Cat Graham, Alistair McKeown, Mike Bennett, Claire O'Neill, Andrew Wilcock, Caroline Usborne, Kenneth C. Fearon, Marie Fallon, Barry J. Laird, on behalf of the IPAC Study Group

The Oncologist first published on April 11, 2019; doi:10.1634/theoncologist.2018-0474


Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Rocio Garcia-Carbonero, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Javier Martinez-Trufero, Miguel Angel Cabrera, Jose Maria Piulats, Jaume Capdevila, Enrique Grande, Salvador Martin-Algarra, Alfonso Berrocal

The Oncologist first published on April 8, 2019; doi:10.1634/theoncologist.2018-0718


HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer

Andrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, Silvia Ghezzi, Sara Lonardi, Francesco Leone, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli, Beatrice Borelli, Federica Tosi, Patrizia Racca, Emanuele Valtorta, Emanuela Bonoldi, Cosimo Martino, Caterina Vaghi, Giovanna Marrapese, Fortunato Ciardiello, Vittorina Zagonel, Alberto Bardelli, Livio Trusolino, Valter Torri, Silvia Marsoni, Salvatore Siena

The Oncologist first published on April 5, 2019; doi:10.1634/theoncologist.2018-0785


Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial

Chiara Nicolazzo, Gian Maria Busetto, Angela Gradilone, Isabella Sperduti, Francesco del Giudice, Flavia Loreni, Enrico Cortesi, Ettore de Berardinis, Paola Gazzaniga, Cristina Raimondi

The Oncologist first published on April 3, 2019; doi:10.1634/theoncologist.2018-0784


Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, Carlo Visco, Monica Tani, Nicola Cascavilla, Annarita Conconi, Monica Balzarotti, Maria Christina Cox, Dario Marino, Maria Cecilia Goldaniga, Roberto Marasca, Cristina Tecchio, Caterina Patti, Gerardo Musuraca, Liliana Devizzi, Federico Monaco, Alessandra Romano, Angelo Fama, Michelle Zancanella, Rossella Paolini, Luigi Rigacci, Claudia Castellino, Francesco Gaudio, Lisa Argnani, Pier Luigi Zinzani

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2018-0603


Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy

Jan Trøst Jørgensen

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2019-0054


The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer

Aristotelis Bamias, Kimon Tzannis, Christina Bamia, Lauren C. Harshman, Simon Crabb, Elizabeth R. Plimack, Sumanta Pal, Ugo De Giorgi, Sylvain Ladoire, Christine Theodore, Neeraj Agarwal, Evan Y. Yu, Guenter Niegisch, Cora N. Sternberg, Sandy Srinivas, Ulka Vaishampayan, Andrea Necchi, Michalis Liontos, Jonathan E. Rosenberg, Thomas Powles, Joaquim Bellmunt, Matthew D. Galsky

The Oncologist first published on April 1, 2019; doi:10.1634/theoncologist.2018-0739


Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

Angela Lamarca, Joakim Crona, Maxime Ronot, Marta Opalinska, Carlos Lopez Lopez, Daniela Pezzutti, Pavan Najran, Luciana Carvhalo, Regis Otaviano Franca Bezerra, Philip Borg, Naik Vietti Violi, Hector Vidal Trueba, Louis de Mestier, Niklaus Schaefer, Anders Sundin, Frederico Costa, Marianne Pavel, Clarisse Dromain, on behalf of The Knowledge Network

The Oncologist first published on March 25, 2019; doi:10.1634/theoncologist.2018-0672


The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia

Sahra Ali, Helen-Marie Dunmore, Dominik Karres, Justin L. Hay, Tomas Salmonsson, Christian Gisselbrecht, Sinan B. Sarac, Ole W. Bjerrum, Doris Hovgaard, Yolanda Barbachano, Nithyanandan Nagercoil, Francesco Pignatti

The Oncologist first published on March 21, 2019; doi:10.1634/theoncologist.2019-0025


Care for Smoking Cessation Must Be Proactive and Based on a Combination of Pharmacology and Psychology

Alain Braillon

The Oncologist first published on March 19, 2019; doi:10.1634/theoncologist.2018-0817


Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.

Cécile Barbaret, Marvin O. Delgado-Guay, Stéphane Sanchez, Christelle Brosse, Murielle Ruer, Léa Monsarrat, Patrick Michaud, Anne Marie Schott, Eduardo Bruera, Mariléne Filbet

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0353


Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor

Javier Molina-Cerrillo, Enrique Grande, Teresa Alonso-Gordoa

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0776


Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas

My Le, Ytel Garcilazo, Maria-José Ibáñez‐Juliá, Nadia Younan, Louis Royer-Perron, Marion Benazra, Karima Mokhtari, Caroline Houillier, Khê Hoang‐Xuan, Agusti Alentorn

The Oncologist first published on March 13, 2019; doi:10.1634/theoncologist.2018-0629


Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Sanchez, Sergio Vázquez, Narayanan Srihari, Haralabos Kalofonos, Petri Bono, Chaitali Babanrao Pisal, Yulia Hirschberg, Luca Dezzani, Qasim Ahmad, Eric Jonasch, on behalf of the PRINCIPAL Study Group

The Oncologist first published on March 13, 2019; doi:10.1634/theoncologist.2018-0787


Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series

Martin Benesch, Martin Mynarek, Hendrik Witt, Monika Warmuth‐Metz, Torsten Pietsch, Brigitte Bison, Stefan M. Pfister, Kristian W. Pajtler, Marcel Kool, Ulrich Schüller, Klaus Pietschmann, Björn‐Ole Juhnke, Stephan Tippelt, Gudrun Fleischhack, Irene Schmid, Christof M. Kramm, Peter Vorwerk, Andreas Beilken, Carl Friedrich Classen, Pablo Hernáiz Driever, Gabriele Kropshofer, Thomas Imschweiler, Andreas Lemmer, Rolf‐Dieter Kortmann, Stefan Rutkowski, Katja von Hoff

The Oncologist first published on March 8, 2019; doi:10.1634/theoncologist.2018-0489


From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

Giulia Pasello, Giovanni Vicario, Fable Zustovich, Francesco Oniga, Stefania Gori, Francesco Rosetti, Andrea Bonetti, Adolfo Favaretto, Silvia Toso, Roberta Redelotti, Antonio Santo, Daniele Bernardi, Petros Giovanis, Cristina Oliani, Lorenzo Calvetti, Carlo Gatti, Giovanni Palazzolo, Zora Baretta, Alberto Bortolami, Laura Bonanno, Marco Basso, Jessica Menis, Donatella Da Corte, Stefano Frega, Valentina Guarneri, PierFranco Conte, on behalf of Veneto Oncology Network

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0712


The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer

Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da Costa Jr, Diana Noronha Nunes, Emmanuel Dias-Neto, Ludmilla T. Domingos Chinen

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0741


Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability

Amanda Hanora Lavan, Deirdre O'Mahony, Mary Buckley, Denis O'Mahony, Paul Gallagher

The Oncologist first published on March 4, 2019; doi:10.1634/theoncologist.2018-0476


European Articles Archive

Links to other domains will open in a new tab or window.